期刊文献+

珍贵束丝放线菌固体发酵生产安丝菌素及安丝菌素P-0制备 被引量:3

Solid-state fermentation of Actinosynnema pretiosum ATCC 31565 for ansamitocins and preparation of ansamitocin P-0
在线阅读 下载PDF
导出
摘要 目的获得安丝菌素及安丝菌素P-0纯品。方法珍贵束丝放线菌ATCC 31565经固体发酵培养,培养物乙酸乙酯萃取、硅胶柱层析后得到安丝菌素P-2、P-3和P-4混合物。安丝菌素混合物经化学法脱去C-3酰基侧链,采用制备型HPLC获得安丝菌素P-0纯品。结果每升固体发酵培养基可获得安丝菌素P-2、P-3和P-4混合物(98±2)mg(纯度85%)。50mg该安丝菌素样品可获得安丝菌素P-0纯品约31mg(纯度大于99%),产率约82%。结论将安丝菌素固体发酵培养与提取、去酰基化和HPLC纯化相结合,建立了一套安丝菌素P-0纯品的实验室制备工艺。 Objective To produce ansamitocins (a mixture of P-2, P-3 and P-4) by Actinosynnema pretiosum ATCC 31565 and obtain ansamitocin P-0 by chemical de-acylation of ansamitocins. Methods Solid-state fermentation of A. pretiosum ATCC 31565 was carried out for ansamitocins production. Ethyl acetate extraction andsilica gel column fractionation were conducted to obtain the mixture preparation of ansamitocins P-2, P-3 and P-4. The mixture was then used to generate ansamitocin P-0 by chemical de-acylation. Results Mixture of ansamitocins (purity ≥85% by HPLC) was obtained at a yield of (98±2)mg/L. The yield of ansamitocin P-0 (purity ≥ 99% by HPLC) was about 82% from ansamitocins. Conclusion A simple and efficient procedure for laboratory production of ansamitocins and ansamitocin P-0 was established.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2015年第4期241-244,273,共5页 Chinese Journal of Antibiotics
基金 "重大新药创制"科技重大专项(No.2012ZX09301002-001-016) 中国医学科学院医药生物技术研究所中央级公益性科研院所基本科研业务专项(No.IMBF201302)
关键词 安丝菌素P-0 珍贵束丝放线菌ATCC31565 固体发酵 Ansamitocin P-O Actinosynnema pretiosum Solid-state fermentation
  • 相关文献

参考文献10

  • 1Tanida S, Hasegawa T, Hatano K, et al. Ansamitocins,maytansinoid antitumor antibiotics. Producing organism fermentation, and antimicrobial activities[J]. J Antibiot (Tokyo), 1980, 33(2): 192-198.
  • 2Hasegawa T, Izawa M, Nagaokakyo T, et al. Antibiotic C-15003 PHM and production thereof: US, 4450234[P]. 1984-05-22.
  • 3Higashide E, Asai M, Ootsu K, et al. Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia [J]. Nature, 1977, 270(5639): 721-722.
  • 4LoRusso P M, Weiss D, Guardino E, et al. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer [J]. Clin Cancer Res, 2011, 17(20): 6437-6447.
  • 5伊丹,王岩,陈少欣.安丝菌素P-3的发酵工艺[J].中国医药工业杂志,2012,43(4):260-262. 被引量:9
  • 6Yao Y Q, Cheng Z H, Ye H Y, et al. Preparative isolation and purification of anti-tumor agent ansamitocin P-3 from fermentation broth ofActinosynnema pretiosum using high- performance counter-current chromatography[J]. J Sep Sci, 2010, 33: 1331- 1337.
  • 7Widdison W C, Wilhelms D, Cavanagh E E, et al. semisynthetic maytansine analogues for the targeted treatment of cancer [J]. JMed Chem, 2006, 49(14): 4392 -4408.
  • 8Lu C H, Bai L Q, shen Y M. A novel amide N-glycoside of ansamitocins from Actinosynnema pretiosum[J]. J Antibiot (Tokyo), 2004, 57(5): 348-350.
  • 9Lin J, Bai L, Deng Z, et al. Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum[J]. Bioresour Technol, 2011, 102(2): 1863-1868.
  • 10钟建江,林锦霞.安丝菌素的固体发酵方法:CN,101319241A[P].2008-12-10.

二级参考文献5

  • 1Higashide E,Asai M,Ootsu K. Ansamitocin,a group of novel maytansinoid antibiotics with antitumour properties from Nocardia[J].Nature,1977,(5639):721-722.
  • 2Cassady JM,Chan KK,Floss HG. Recent developments in the maytansinoid antitumor agents[J].Chemical and Pharmaceutical Bulletin(Tokyo),2004,(01):1-26.doi:10.1248/cpb.52.1.
  • 3Liu C,Tadayoni BM,Bourret LA. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids[J].Proceedings of the National Academy of Sciences(USA),1996,(16):8618-8623.doi:10.1073/pnas.93.16.8618.
  • 4Hasegawa T,Izawa M,Nagaokakyo T. Antibiotic C-15003 PHM and production thereof[P].US,4450234,1984.
  • 5Lin J,Bai L,Deng Z. Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum[J].Bioresource Technology,2011,(02):1863-1868.

共引文献8

同被引文献13

  • 1LI Tinglan, FAN Yuxiang, NAMBOU K, et al. Improvement of ansamitoein P-3 production by Actinosynnema mirum with fructose as the sole carbon source[J]. Applied Biochemistry and Biotechnology, 2015, 175(6): 2845-2856.
  • 2GAO Yang, FAN Yuxiaug, Nambou K, et al. Enhancement of ansamitocin P-3 production in Actinosynnema pretiosum by a synergistic effect of glycerol and glucose[J]. Journal of Industrial Microbiology & Biotechnology, 2014, 41(1): 143-152.
  • 3JURJENS G, KIRSCHNING A. Synthesis of a cytotoxic ansamycin hybrid[J]. Organic Letters, 2014, 16(11): 3000-3003.
  • 4SCHWENK D, NE'Iq" M, DAHSE H M, et al. Injury-induced biosynthesis of methyl-branched polyene pigments in a white- rotting basidiomycete[J]. Journal of Natural Products, 2014, 77 (12): 2658-2663.
  • 5NEWMAN D J, GIDDINGS L A. Natural products as leads to antitumor drugs[J]. Phytochemistry Reviews, 2014, 13(1): 123-137.
  • 6EICHNER S, KNOBLOCH T, FLOSS H G, et al. The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library[J]. Angewandte Chemic Intemational Edition, 2012, 51(3): 752-757.
  • 7TAFT F, HARMROLFS K, NICKELEIT I, et al. Combined muta-and semisynthesis: A powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3[J]. Chemistry-A European Journal, 2012, 18(3): 880-886.
  • 8伊丹,王岩,陈少欣.安丝菌素P-3的发酵工艺[J].中国医药工业杂志,2012,43(4):260-262. 被引量:9
  • 9汪晨,蔡恒,张恒丽,张凯,欧阳平凯.高产琥珀酸菌株的等离子体诱变选育[J].南京工业大学学报(自然科学版),2013,35(1):57-60. 被引量:12
  • 10李慧玲,刘祖艳,赵敏.产β-甘露聚糖酶菌株的物理和化学诱变育种研究[J].安徽农业科学,2014,42(18):5741-5741. 被引量:4

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部